| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Division of Endocrinology, Departments of Medicine (M.J.V., T.S.), Obstetrics and Gynecology (A.T.), Clinical Chemistry (H.A., U.-H.S.), Pathology (A.Pa.), and Neurosurgery (A.Po.), Helsinki University Central Hospital, FIN-00290 Helsinki, Finland
Address all correspondence and requests for reprints to: Dr. Matti J. Välimäki, M.D., Ph.D., Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, FIN-00290 Helsinki, Finland. E-mail: matti.valimaki{at}huch.fi
Ovarian hyperstimulation caused by a gonadotroph adenoma in
premenopausal women has been described only twice before this report. A
28-yr-old woman presented with menstrual disturbances and pelvic pains
that began after stopping the use of contraceptive pills. Transvaginal
ultrasound revealed enlarged ovaries with multiple cysts. The patient
had elevated serum estradiol (up to 2900 pmol/L; normal, 80300 pmol/L
in the follicular phase) and inhibin (6.4 kU/L; normal, 0.52.5 kU/L)
levels. Serum LH was appropriately suppressed (0.6 IU/L), but serum FSH
varied from 4.98.1 IU/L. Both gonadotropins as well as the free
-subunit showed a paradoxical response to the stimulus by TRH. A
nuclear magnetic resonance study unraveled a pituitary tumor, 1214 mm
in diameter, extending up to the suprasellar cistern. After pituitary
surgery, all hormone values normalized, and the patient resumed regular
ovulatory cycles. In immunostaining, 2030% of the cells of the tumor
stained positively for FSHß. We conclude that a
gonadotropin-producing adenoma must be considered in the differential
diagnosis of a patient presenting with large multicystic ovaries and
high estradiol levels in the absence of exogenous gonadotropins.
This article has been cited by other articles:
![]() |
T. Kajitani, S. Liu, T. Maruyama, H. Uchida, R. Sakurai, H. Masuda, T. Nagashima, M. Ono, T. Arase, and Y. Yoshimura Analysis of serum FSH bioactivity in a patient with an FSH-secreting pituitary microadenoma and multicystic ovaries: A case report Hum. Reprod., February 1, 2008; 23(2): 435 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ghayuri and J. H. Liu Ovarian Hyperstimulation Syndrome Caused by Pituitary Gonadotroph Adenoma Secreting Follicle-Stimulating Hormone Obstet. Gynecol., February 1, 2007; 109(2): 547 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Miro, S. W. Parker, L. J. Aspinall, J. Coley, P. W. Perry, and J. E. Ellis Origins and Consequences of the Elongation of the Human Menstrual Cycle during the Menopausal Transition: The FREEDOM Study J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4910 - 4915. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Murata, H. Ando, T. Nagasaka, I. Takahashi, K. Saito, H. Fukugaki, K. Matsuzawa, and S. Mizutani Successful Pregnancy after Bromocriptine Therapy in an Anovulatory Woman Complicated with Ovarian Hyperstimulation Caused by Follicle-Stimulating Hormone-Producing Plurihormonal Pituitary Microadenoma J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1988 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shimon, T. Rubinek, I. Bar-Hava, D. Nass, M. Hadani, A. Amsterdam, and G. Harel Ovarian Hyperstimulation without Elevated Serum Estradiol Associated with Pure Follicle-Stimulating Hormone-Secreting Pituitary Adenoma J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3635 - 3640. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |